Skip to main content

Min soo Park

Yonsei University · Medicine

About the Lab

Professor Min soo Park's research lab focuses on translational and clinical research in oncology, particularly in soft tissue sarcomas such as hemangiopericytoma/soft tissue sarcoma (HPC/SFT), aiming to identify molecular targets for personalized, targeted therapies. The lab also investigates cardioprotective pathways involving the nitric oxide and cGMP signaling axis, with an emphasis on novel therapeutic strategies for heart failure and ischemia/reperfusion injury. Additionally, the lab conducts clinical studies in neonatal sepsis diagnostics, ophthalmic surgery (e.g., endonasal dacryocystorhinostomy and entropion repair), and rare congenital disorders such as aplasia cutis congenita with complex multisystem anomalies.

soft tissue sarcomacardioprotectionneonatal sepsisophthalmic surgerycongenital anomalies

Research Overview

Papers
471
Total Citations
4,984
Papers (5y)
40
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
40total
2022
2023
2024
2025
2026
Citations per year (5y)
267total
20222023202420252026

Selected Papers

15
1
Review|173 citations·2009
New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors
Min Soo Park, Dejka M. Araujo
SJR Q2Current Opinion in Oncology

With many novel targeted therapies currently in development for soft tissue sarcomas, a better understanding of the molecular pathogenesis and aberrations of HPC/SFT is needed to determine optimal therapeutic agents. Identifying appropriate targets and designing rational prospective clinical trials will not only improve treatment of HPC/SFT but will also lead to a new paradigm of personalized, targeted therapy.

RheumatologyMedicine
2
Review|79 citations·2018
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
Min Soo Park, Peter Sandner, Thomas Krieg
SJR Q1Basic Research in CardiologyOA

The nitric oxide (NO)-protein kinase G (PKG) pathway has been known for some time to be an important target for cardioprotection against ischaemia/reperfusion injury and heart failure. While many approaches for reducing infarct size in patients have failed in the past, the advent of novel drugs that modulate cGMP and its downstream targets shows very promising results in recent preclinical and clinical studies. Here, we review main aspects of the NO-PKG pathway in light of recent drug developmen

PhysiologyMedicine
3
Article|51 citations·2007
Altered Expressions of Fibroblast Growth Factor Receptors and Alveolarization in Neonatal Mice Exposed to 85% Oxygen
Min Soo Park, Esther Rieger‐Fackeldey, Brandon Schanbacher, Angela C. Cook, John Anthony Bauer, Lynette K. Rogers, Thomas N. Hansen, Stephen E. Welty, Charles V. Smith
SJR Q1Pediatric ResearchOA
Pulmonary and Respiratory MedicineMedicine
4
Article|39 citations·2008
Design and synthesis of 6-amino-1,4-oxazepane-3,5-dione derivatives as novel broad spectrum anticonvulsants
Gitalee Sharma, Jin Yup Park, Min Soo Park
SJR Q2Bioorganic & Medicinal Chemistry Letters
Organic ChemistryChemistry
5
Article|27 citations·2012
Usefulness of the delta neutrophil index for assessing neonatal sepsis
Soon Min Lee, Ho Seon Eun, Ran Namgung, Min Soo Park, Kook I Park, Chul Lee
SJR Q1Acta PaediatricaOA

AIM: We investigated the significance of the calculated delta neutrophil index (DNI) as a diagnostic factor for neonatal sepsis. METHODS: In retrospective study, 24 infants were diagnosed with blood culture-proven sepsis, and 48 non-septic neonates matched for gestational age, and birth weight served as controls. Among the 24 infants with sepsis, 5 died within 7 days at diagnosis. RESULTS: Mean DNI (at diagnosis, after 24 h and 72 h), CRP and WBC counts were significantly higher, and neutrophil

Public Health, Environmental and Occupational HealthMedicine
6
Article|24 citations·1996
Synthesis and anticonvulsant evaluation of a series of (R)- and (S)-N-Cbz-α-aminoglutarimide and succinimide
Min Soo Park, Jaewon Lee, Jongwon Choi
SJR Q2Bioorganic & Medicinal Chemistry Letters
Organic ChemistryChemistry
7
Article|23 citations·2006
Clinical Study of Endoscopic Endonasal Conjunctivodacryocystorhinostomy with Jones Tube Placement
Min Soo Park, Mi Jung Chi, Se Hyun Baek
SJR Q1Ophthalmologica

PURPOSE: To evaluate the efficacy of endoscopic endonasal primary conjunctivodacryocystorhinostomy (CDCR) and revision CDCR after primary CDCR. METHODS: Twenty-four patients who had undergone endoscopic endonasal CDCR with a Jones tube and who were followed up for over 6 months at our hospital were reviewed retrospectively. Our analysis included success rate, operation times, and causes of failure. RESULTS: The indications for revision CDCR were Jones tube prolapse and inadequate tube length. Th

OphthalmologyMedicine
8
Article|16 citations·2015
CCN3 overexpression inhibits growth of callosal projections via upregulation of RAB25
Min Soo Park, In‐Jeoung Baek, Hyunduk Kim, Dong Kyun Woo, Young‐Jun Park, Sungbo Shim
SJR Q2Biochemical and Biophysical Research Communications
Molecular BiologyBiochemistry, Genetics and Molecular Biology
9
Article|16 citations·2008
Synthesis and anticonvulsant evaluation of 6-amino-1,4-oxazepane-3,5-dione derivatives
Gitalee Sharma, Jin Yup Park, Min Soo Park
SJR Q1Archives of Pharmacal Research
Organic ChemistryChemistry
10
Article|15 citations·2006
Clinical Study of Single-Suture Inferior Retractor Repair for Involutional Entropion
Min Soo Park, Mi Jung Chi, Se Hyun Baek
SJR Q1Ophthalmologica

PURPOSE: To evaluate the clinical efficacy of a simplified single-suture inferior retractor repair technique for involutional entropion. METHODS: A retrospective study of 20 patients (26 eyelids), followed for 6 months at our hospital, who showed no severe horizontal lid laxity were operated on for involutional entropion. After subciliary incision, the inferior retractor was identified and repaired by reattaching the superior edge of the inferior retractor to the inferior edge of the lower tarsu

DermatologyMedicine
11
Article|15 citations·1998
Extensive form of aplasia cutis congenita: a new syndrome?
Min Soo Park, Si Houn Hahn, Catherine Hong, J. S. Kim, Hyo Song Kim
SJR Q1Journal of Medical GeneticsOA

Aplasia cutis congenita is a heterogeneous group of conditions usually involving the scalp as well as any other part of the body and is associated with a number of other congenital anomalies. We report on a newborn male with almost complete absence of skin and subcutaneous tissue in association with choanal atresia, syndactyly, imperforate anus, pulmonary hypoplasia, and other anomalies. To our knowledge, this condition, not only in the extent of the lesion but the associated anomalies, has not

Cell BiologyBiochemistry, Genetics and Molecular Biology
12
Article|13 citations·2013
Measurement of Fracture Size Using the Picture Archiving Communication System in an Outpatient Clinic for Factors that Influence Postoperative Enophthalmos in Adult Inferior Orbital Wall Fractures
Min Soo Park, Sehyun Baek
SJR Q2Journal of Craniofacial Surgery

In our study, fracture size was a better predictive factor for postoperative enophthalmos than preoperative exophthalmometric measurement. With our method, postoperative enophthalmos can be predicted more conveniently in a clinical setting, and decisions regarding the timing of early surgical reduction were made easier.

SurgeryMedicine
13
Article|12 citations·2015
Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects
Choon Ok Kim, Eun Sil Oh, Chin Kim, Min Soo Park
SJR Q1Clinical TherapeuticsOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
14
Article|11 citations·1999
The effect ofN-substituted alkyl groups on anticonvulsant activities ofN-Cbz-α-amino-N-alkylglutarimides
Jaewon Lee, Kichun Son, Min Jeong Kim, Gyungim Jung, Jongwon Choi, Eung-Seok Lee, Min Soo Park
SJR Q1Archives of Pharmacal Research
Organic ChemistryChemistry
15
Article|11 citations·2018
Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study
Byung Hak Jin, Byung Won Yoo, Jungsin Park, Jung Hye Kim, Jun Yeon Lee, Jae Soo Shin, Min Soo Park
SJR Q2European Journal of Clinical PharmacologyOA

Ilaprazole, the latest proton pump inhibitor, can be used with clarithromycin and amoxicillin as a triple therapy regimen for eradicating Helicobacter pylori. The aim of this study was to evaluate pharmacokinetic drug interactions and safety profiles after coadministration of clarithromycin, amoxicillin, and ilaprazole. A randomised, open-label, one-way crossover, two parallel sequences study was conducted in 32 healthy subjects. In part 1, the subjects received a single dose of ilaprazole 10 mg

SurgeryMedicine

Research Areas

Aerospace EngineeringPulmonary and Respiratory MedicineSurgeryOphthalmologyDermatologyPublic Health, Environmental and Occupational Health

Dive deeper into Min soo Park's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.